Desirable properties for coating compositions suitable for use in roofing applications are set, for example, by the American Society for Testing Materials (ASTM). ASTM D 6083-05 specifies that desirable properties of roof coatings include high tensile strength, high elongation, high flexibility, and mandrel bend performance at low temperatures. At the present time, roof coatings that meet these performance properties are typically based on polyurethane, silicone or polyvinyl chloride (PVC) polymers or copolymers. However, these coatings are often solvent borne and expensive. Thus, there is a need in the art to provide coating compositions that are able to achieve and even exceed the desired performance properties set forth in ASTM D 6083-05 at a cost effective level.
Coating compositions and methods for their preparation are described. The coating compositions comprise a first copolymer and a second copolymer. In some embodiments, the coating compositions can include a first copolymer produced by emulsion polymerization and derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The first copolymer can have a Tg from −50° C. to −23° C. and is present in an amount of 10-50% by weight based on the total polymer content. The coating compositions also include a second copolymer produced by emulsion polymerization and derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The second copolymer can have a Tg from −15° C. to 25° C. and is present in an amount of 50-90% by weight based on the total polymer content. The coating compositions can further include a filler comprising at least one pigment, a pigment dispersing agent, a thickener, a defoamer, a surfactant, and water. The coating composition can have a viscosity of from 12,000 to 85,000 cps at 25° C., a volume solids of greater than 50%, and a weight solids of greater than 60%. Also, the coating composition, when applied as a film, dried and weathered for 1000 hours, can pass the mandrel bend test set forth in ASTM D 6083-05 at at −26° C. and can optionally have a tensile strength of greater than 300 psi.
The at least one first copolymer can be present in an amount of 20-30% by weight based on the total polymer content. In some examples, the first copolymer has a Tg of from −36° C. to −23° C. The second copolymer can have a Tg of from −12° C. to 0° C. In some examples, at least one of the first copolymer and the second copolymer is a styrene acrylic copolymer. In some examples, the first copolymer and the second copolymer are pure acrylics. The first copolymer and the second copolymer can each be derived from at least one low Tg monomer selected from the group consisting of butyl acrylate and 2-ethylhexyl acrylate. Optionally, at least one of the first copolymer and the second copolymer are further derived from at least one high Tg monomer selected from the group consisting of methyl methacrylate and styrene. At least one of the first copolymer and the second copolymer can be derived from a crosslinkable monomer. The acid monomers in the first copolymer and the second copolymer can each be selected from the group consisting acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and mixtures thereof. At least one of the first copolymer and the second copolymer can be further derived from (meth)acrylamide.
The coating composition can further include one or more of a biocide, a dispersing agent, and a coalescing agent. In some examples, the coating composition can further include a quick setting additive (e.g., a polyamine such as polyethyleneimine or a derivatized polyamine such as an alkoxylated polyethyleneimine).
In other embodiments, the coating compositions can comprise a composition including a first copolymer and a second copolymer. In these examples, the first copolymer is produced by emulsion polymerization and derived from one or more monomers including one of more of butyl acrylate and 2-ethylhexyl acrylate, one or more acid monomers, a crosslinkable monomer, and optionally styrene or methyl methacrylate. The first copolymer can have a Tg from −36° C. to −23° C. In these examples, the second copolymer is produced by emulsion polymerization and derived from one or more monomers including one of more of butyl acrylate and 2-ethylhexyl acrylate, one or more acid monomers, a crosslinkable monomer, and optionally styrene or methyl methacrylate. The second copolymer can have a Tg from −12° C. to 0° C. The first copolymer and the second copolymer can be dispersed in an aqueous medium.
Also described herein are dried coatings. The dried coatings can be formed by drying a composition as described herein.
Further described herein are methods of coating a substrate. The method can include applying a coating composition as described herein to a surface. In some examples, the surface is a roof surface. In some examples, the surface is a wall.
Methods of producing a coating are also provided herein. The methods include mixing a composition as described herein with a filler comprising at least one pigment, a dispersing agent, a thickener, a defoamer, and a stabilizer.
The details of one or more embodiments are set forth in the description below. Other features, objects, and advantages will be apparent from the description and from the claims.
Acrylic dispersion-based coating compositions and methods of their preparation and use are described herein. The coating compositions include a first copolymer and a second copolymer. The first copolymer described herein can be derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene. The second copolymer described herein can be derived from one or more monomers including one or more (meth)acrylates, one or more acid monomers, and optionally styrene.
The one or more (meth)acrylates can include esters of α,β-monoethylenically unsaturated mono- and dicarboxylic acids having 3 to 6 carbon atoms with alkanols having 1 to 12 carbon atoms (e.g., esters of acrylic acid, methacrylic acid, maleic acid, fumaric acid, or itaconic acid, with C1-C12, C1-C8, or C1-C4 alkanols). In some examples, the one or more (meth)acrylates for preparing the first copolymer and/or second copolymer are selected from butyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, and mixtures of these.
The one or more acid monomers can include α,β-monoethylenically unsaturated mono- and dicarboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, crotonic acid, dimethacrylic acid, ethylacrylic acid, allylacetic acid, vinylacetic acid, mesaconic acid, methylenemalonic acid, or citraconic acid). In some examples, the one or more acid monomers for preparing the first copolymer and/or second copolymer are selected from the group consisting acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, and mixtures of these.
Optionally, the first copolymer and the second copolymer are each derived from at least one low glass transition temperature (Tg) monomer. As used herein, a low Tg monomer refers to a monomer having a Tg value of less than −40° C. for the corresponding homopolymer. Examples of suitable low Tg monomers include butyl acrylate (Tg value of −43° C.) and 2-ethylhexyl acrylate (Tg value of −58° C.).
Optionally, the first copolymer and the second copolymer are each derived from at least one high Tg monomer. As used herein, a high Tg monomer refers to a monomer having a Tg value of greater than 40° C. for the corresponding homopolymer. Examples of suitable high Tg monomers include methyl methacrylate (Tg value of 105° C.) and styrene (Tg value of 100° C.).
In some embodiments, at least one of the first copolymer and the second copolymer is further derived from an acrylamides or an alkyl-substituted acrylamide. Suitable examples include N-tert-butylacrylamide and N-methyl(meth)acrylamide. In some embodiments, at least one of the first copolymer and the second copolymer is further derived from (meth)acrylamide.
Optionally, at least one of the first copolymer and the second copolymer is derived from a crosslinkable monomer. For example, the crosslinkable monomer can include diacetone acrylamide (DAAM) or a self-crosslinking monomer such as a monomer comprising 1,3-diketo groups (e.g., acetoacetoxyethyl(meth)acrylate) or a silane crosslinker. Examples of suitable silane crosslinkers include 3-methacryloxypropyl trimethoxysilane, 3-mercaptopropyl trimethoxysilane, vinyltriethoxysilane, and polyvinyl-siloxane oligomers such as DYNASYLAN 6490, a polyvinyl siloxane oligomer derived from vinyltrimethoxysilane, and DYNASYLAN 6498, a polyvinyl siloxane oligomer derived from vinyltriethoxysilane, both commercially available from Evonik Degussa GmbH (Essen, Germany) The polyvinyl siloxane oligomer can have the following structure:
wherein n is an integer from 1 to 50 (e.g., 10). Crosslinkable monomers as described herein can further include monomers such as divinylbenzene; 1,4-butanediol diacrylate; methacrylic acid anhydride; and monomers containing urea groups (e.g., ureidoethyl(meth)acrylate, acrylamidoglycolic acid, and methacrylamidoglycolate methyl ether. Additional examples of crosslinkable monomers include N-alkylolamides of α,β-monoethylenically unsaturated carboxylic acids having 3 to 10 carbon atoms and esters thereof with alcohols having 1 to 4 carbon atoms (e.g., N-methylolacrylamide and N-methylolmethacrylamide); glyoxal based crosslinkers; monomers containing two vinyl radicals; monomers containing two vinylidene radicals; and monomers containing two alkenyl radicals. Exemplary crosslinkable monomers include diesters or triesters of dihydric and trihydric alcohols with α,β-monoethylenically unsaturated monocarboxylic acids (e.g., di(meth)acrylates, tri(meth)acrylates), of which in turn acrylic acid and methacrylic acid can be employed. Examples of such monomers containing two non-conjugated ethylenically unsaturated double bonds are alkylene glycol diacrylates and dimethacrylates, such as ethylene glycol diacrylate, 1,3-butylene glycol diacrylate, 1,4-butylene glycol diacrylate and propylene glycol diacrylate, vinyl methacrylate, vinyl acrylate, allyl methacrylate, allyl acrylate, diallyl maleate, diallyl fumarate and methylenebisacrylamide. In some examples, the first copolymer and/or the second copolymer can include from 0 to 5% by weight of one or more crosslinkable monomers.
The first copolymer and/or second copolymer can further include additional monomers. Further examples of additional monomers include vinylaromatics such as α- and p-methylstyrene, α-butylstyrene, 4-n-butylstyrene, 4-n-decylstyrene, and vinyltoluene; conjugated dienes (e.g., isoprene); anhydrides of α,β-monoethylenically unsaturated mono- and dicarboxylic acids (e.g., maleic anhydride, itaconic anhydride, and methylmalonic anhydride); (meth)acrylonitrile; vinyl and vinylidene halides (e.g., vinyl chloride and vinylidene chloride); vinyl esters of C1-C18 mono- or dicarboxylic acids (e.g., vinyl acetate, vinyl propionate, vinyl n-butyrate, vinyl laurate and vinyl stearate); C1-C4 hydroxyalkyl esters of C3-C6 mono- or dicarboxylic acids, especially of acrylic acid, methacrylic acid or maleic acid, or their derivatives alkoxylated with from 2 to 50 moles of ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, or esters of these acids with C1-C18 alcohols alkoxylated with from 2 to 50 mol of ethylene oxide, propylene oxide, butylene oxide or mixtures thereof (e.g., hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, and methylpolyglycol acrylate); and monomers containing glycidyl groups (e.g., glycidyl methacrylate).
Further examples of additional monomers or co-monomers that can be used include linear 1-olefins, branched-chain 1-olefins or cyclic olefins (e.g., ethene, propene, butene, isobutene, pentene, cyclopentene, hexene, and cyclohexene); vinyl and allyl alkyl ethers having 1 to 40 carbon atoms in the alkyl radical, wherein the alkyl radical can possibly carry further substituents such as a hydroxyl group, an amino or dialkylamino group, or one or more alkoxylated groups (e.g., methyl vinyl ether, ethyl vinyl ether, propyl vinyl ether, isobutyl vinyl ether, 2-ethylhexyl vinyl ether, vinyl cyclohexyl ether, vinyl 4-hydroxybutyl ether, decyl vinyl ether, dodecyl vinyl ether, octadecyl vinyl ether, 2-(diethylamino)ethyl vinyl ether, 2-(di-n-butylamino)ethyl vinyl ether, methyldiglycol vinyl ether, and the corresponding allyl ethers); sulfo-functional monomers (e.g., allylsulfonic acid, methallylsulfonic acid, styrenesulfonate, vinylsulfonic acid, allyloxybenzenesulfonic acid, 2-acrylamido-2-methylpropanesulfonic acid, and their corresponding alkali metal or ammonium salts, sulfopropyl acrylate and sulfopropyl methacrylate); phosphorus-containing monomers (e.g., dihydrogen phosphate esters of alcohols in which the alcohol contains a polymerizable vinyl or olefenic group, allyl phosphate, phosphoalkyl(meth)acrylates such as 2-phosphoethyl(meth)acrylate (PEM), 2-phosphopropyl(meth)acrylate, 3-phosphopropyl(meth)acrylate, and phosphobutyl(meth)acrylate, 3-phospho-2-hydroxypropyl(meth)acrylate, mono- or di-phosphates of bis(hydroxymethyl) fumarate or itaconate; phosphates of hydroxyalkyl(meth)acrylate, 2-hydroxyethyl(meth)acrylate, 3-hydroxypropyl(meth)acrylate, ethylene oxide condensates of (meth)acrylates, H2C═C(CH3)COO(CH2CH2O)nP(O)(OH)2, and analogous propylene and butylene oxide condensates, where n is an amount of 1 to 50, phosphoalkyl crotonates, phosphoalkyl maleates, phosphoalkyl fumarates, phosphodialkyl(meth)acrylates, phosphodialkyl crotonates, vinyl phosphonic acid, allyl phosphonic acid, 2-acrylamido-2methylpropanephosphinic acid, α-phosphonostyrene, 2-methylacrylamido-2-methylpropanephosphinic acid, (hydroxy)phosphinylalkyl(meth)acrylates, (hydroxy)phosphinylmethyl methacrylate, and combinations thereof); alkylaminoalkyl(meth)acrylates or alkylaminoalkyl(meth)acrylamides or quaternization products thereof (e.g., 2-(N,N-dimethylamino)ethyl(meth)acrylate, 3-(N,N-dimethylamino)propyl(meth)acrylate, 2-(N,N,N-trimethylammonium)ethyl(meth)acrylate chloride, 2-dimethylaminoethyl(meth)acrylamide, 3-dimethylaminopropyl(meth)acrylamide, and 3-trimethylammoniumpropyl(meth)acrylamide chloride); allyl esters of C1-C30 monocarboxylic acids; N-vinyl compounds (e.g., N-vinylformamide, N-vinyl-N-methylformamide, N-vinylpyrrolidone, N-vinylimidazole, 1-vinyl-2-methylimidazole, 1-vinyl-2-methylimidazoline, N-vinylcaprolactam, vinylcarbazole, 2-vinylpyridine, and 4-vinylpyridine).
The first copolymer and the second copolymer can independently be pure acrylics, styrene acrylics, or vinyl acrylics. In some embodiments, the first copolymer is a styrene acrylic copolymer (i.e., the first copolymer is a styrene acrylic copolymer, the second copolymer is a styrene acrylic copolymer, or both the first copolymer and the second copolymer are styrene acrylic copolymers). In other embodiments, at least one of the first copolymer and the second copolymer is a pure acrylic (i.e., the first copolymer is a pure acrylic, the second copolymer is a pure acrylic, or both the first copolymer and second copolymer are pure acrylics).
The first copolymer and the second copolymer can be prepared by polymerizing the monomers using free-radical emulsion polymerization. The monomers for the first copolymer and the second copolymer can be prepared as aqueous dispersions. The emulsion polymerization temperature is generally from 30° C. to 95° C. or from 75° C. to 90° C. The polymerization medium can include water alone or a mixture of water and water-miscible liquids, such as methanol. In some embodiments, water is used alone. The emulsion polymerization can be carried out either as a batch, semi-batch, or continuous process. Typically, a semi-batch process is used. In some embodiments, a portion of the monomers can be heated to the polymerization temperature and partially polymerized, and the remainder of the polymerization batch can be subsequently fed to the polymerization zone continuously, in steps or with superposition of a concentration gradient.
The free-radical emulsion polymerization can be carried out in the presence of a free-radical polymerization initiator. The free-radical polymerization initiators that can be used in the process are all those which are capable of initiating a free-radical aqueous emulsion polymerization including alkali metal peroxydisulfates and H2O2, or azo compounds. Combined systems can also be used comprising at least one organic reducing agent and at least one peroxide and/or hydroperoxide, e.g., tert-butyl hydroperoxide and the sodium metal salt of hydroxymethanesulfinic acid or hydrogen peroxide and ascorbic acid. Combined systems can also be used additionally containing a small amount of a metal compound which is soluble in the polymerization medium and whose metallic component can exist in more than one oxidation state, e.g., ascorbic acid/iron(II) sulfate/hydrogen peroxide, where ascorbic acid can be replaced by the sodium metal salt of hydroxymethanesulfinic acid, sodium sulfite, sodium hydrogen sulfite or sodium metal bisulfite and hydrogen peroxide can be replaced by tert-butyl hydroperoxide or alkali metal peroxydisulfates and/or ammonium peroxydisulfates. In the combined systems, the carbohydrate derived compound can also be used as the reducing component. In general, the amount of free-radical initiator systems employed can be from 0.1 to 2%, based on the total amount of the monomers to be polymerized. In some embodiments, the initiators are ammonium and/or alkali metal peroxydisulfates (e.g., sodium persulfate), alone or as a constituent of combined systems. The manner in which the free-radical initiator system is added to the polymerization reactor during the free-radical aqueous emulsion polymerization is not critical. It can either all be introduced into the polymerization reactor at the beginning, or added continuously or stepwise as it is consumed during the free-radical aqueous emulsion polymerization. In detail, this depends in a manner known to an average person skilled in the art both from the chemical nature of the initiator system and on the polymerization temperature. In some embodiments, some is introduced at the beginning and the remainder is added to the polymerization zone as it is consumed. It is also possible to carry out the free-radical aqueous emulsion polymerization under superatmospheric or reduced pressure.
The first or second copolymer can each independently be produced by single stage polymerization or multiple stage polymerization. In some embodiments, the first copolymer and the second copolymer are each copolymerized separately to produce a first dispersion including a plurality of polymer particles including the first copolymer and a second dispersion comprising a plurality of polymer particles including the second copolymer. The first and second dispersions can then be combined to provide a dispersion including the first and second copolymers. In some embodiments, the first copolymer and the second copolymer are provided in the same polymer particle by using multiple stage polymerization such that one of the first copolymer and second copolymer can be present as a first stage copolymer (e.g., as a core in a core/shell polymer particle) and one of the first copolymer and second copolymer can be present as a second stage copolymer (e.g., as a shell in a core/shell polymer particle).
One or more surfactants can be included in the aqueous dispersions to improve certain properties of the dispersions, including particle stability. For example, sodium laureth sulfate and alkylbenzene sulfonic acid or sulfonate surfactants could be used. Examples of commercially available surfactants include Calfoam® ES-303, a sodium laureth sulfate, and Calfax® DB-45, a sodium dodecyl diphenyl oxide disulfonate, both available from Pilot Chemical Company (Cincinnati, Ohio). In general, the amount of surfactants employed can be from 0.01 to 5%, based on the total amount of the monomers to be polymerized.
Small amounts (e.g., from 0.01 to 2% by weight based on the total monomer weight) of molecular weight regulators, such as a mercaptan, can optionally be used. Such substances are preferably added to the polymerization zone in a mixture with the monomers to be polymerized and are considered part of the total amount of unsaturated monomers used in the copolymers.
The first copolymer can have a Tg value of less than −20° C. as measured by differential scanning calorimetry (DSC) by measuring the midpoint temperature using ASTM D 3418-08. For example, the Tg of the first copolymer can be from −50° C. to −23° C., −40° C. to −25° C., or −33° C. to −26° C. In some examples, the Tg of the first copolymer is from −36° C. to −23° C. The second copolymer can have a Tg value of greater than −15° C. For example, the Tg of the second copolymer can be from −12° C. to 25° C., −9° C. to 5° C., or −5° C. to 0° C. In some examples, the Tg of the first copolymer is from −12° C. to 0° C.
The first copolymer can be present in the coating composition in an amount of 10-50% by weight based on the total polymer content. For example, the first copolymer can be present in the coating composition in an amount of 15-35% or 20-30% by weight based on the polymer content. The second copolymer can be present in the coating composition in an amount of 50-90% by weight based on the total polymer content. For example, the second copolymer can be present in the coating composition in an amount of 65-85% or 70-80% by weight based on the total polymer content.
In some embodiments, the first copolymer and the second copolymer can be dispersed in an aqueous medium to form an aqueous dispersion. The aqueous dispersion can be used to form the coating composition. The coating composition can further include at least one filler such as a pigment or extender. The term “pigment” as used herein includes compounds that provide color or opacity to the coating composition. Examples of suitable pigments include metal oxides, such as titanium dioxide, zinc oxide, iron oxide, or combinations thereof. The at least one pigment can be selected from the group consisting of TiO2 (in both anastase and rutile forms), clay (aluminum silicate), CaCO3 (in both ground and precipitated forms), aluminum oxide, silicon dioxide, magnesium oxide, talc (magnesium silicate), barytes (barium sulfate), zinc oxide, zinc sulfite, sodium oxide, potassium oxide and mixtures thereof. Examples of commercially titanium dioxide pigments are KRONOS® 2101, KRONOS® 2310, available from Kronos WorldWide, Inc., TI-PURE® R-900, available from DuPont, or TIONA® AT1 commercially available from Millenium Inorganic Chemicals. Titanium dioxide is also available in concentrated dispersion form. An example of a titanium dioxide dispersion is KRONOS® 4311, also available from Kronos WorldWide, Inc. Suitable pigment blends of metal oxides are sold under the marks Minex® (oxides of silicon, aluminum, sodium and potassium commercially available from Unimin Specialty Minerals), Celite® (aluminum oxide and silicon dioxide commercially available from Celite Company), and Atomite® (commercially available from Imerys Performance Minerals). Exemplary fillers also include clays such as attapulgite clays and kaolin clays including those sold under the Attagel® and Ansilex® marks (commercially available from BASF Corporation). Additional fillers include nepheline syenite, (25% nepheline, 55% sodium feldspar, and 20% potassium feldspar), feldspar (an aluminosilicate), diatomaceous earth, calcined diatomaceous earth, talc (hydrated magnesium silicate), aluminosilicates, silica (silicon dioxide), alumina (aluminum oxide), mica (hydrous aluminum potassium silicate), pyrophyllite (aluminum silicate hydroxide), perlite, baryte (barium sulfate), Wollastonite (calcium metasilicate), and combinations thereof. More preferably, the at least one filler includes TiO2, CaCO3, and/or a clay.
Generally, the mean particle sizes of the filler ranges from about 0.01 to about 50 microns. For example, the TiO2 particles used in the aqueous coating composition typically have a mean particle size of from about 0.15 to about 0.40 microns. The filler can be added to the aqueous coating composition as a powder or in slurry form. The filler is preferably present in the aqueous coating composition in an amount from about 5 to about 50 percent by weight, more preferably from about 10 to about 40 percent by weight (i.e. the weight percentage of the filler based on the total weight of the coating composition).
Examples of suitable pigment dispersing agents are polyacid dispersants and hydrophobic copolymer dispersants. Polyacid dispersants are typically polycarboxylic acids, such as polyacrylic acid or polymethacrylic acid, which are partially or completely in the form of their ammonium, alkali metal, alkaline earth metal, ammonium, or lower alkyl quaternary ammonium salts. Hydrophobic copolymer dispersants include copolymers of acrylic acid, methacrylic acid, or maleic acid with hydrophobic monomers. In certain embodiments, the composition includes a polyacrylic acid-type dispersing agent, such as Pigment Disperser N, commercially available from BASF SE.
Examples of suitable thickeners include hydrophobically modified ethylene oxide urethane (HEUR) polymers, hydrophobically modified alkali soluble emulsion (HASE) polymers, hydrophobically modified hydroxyethyl celluloses (HMHECs), hydrophobically modified polyacrylamide, and combinations thereof. HEUR polymers are linear reaction products of diisocyanates with polyethylene oxide end-capped with hydrophobic hydrocarbon groups. HASE polymers are homopolymers of (meth)acrylic acid, or copolymers of (meth)acrylic acid, (meth)acrylate esters, or maleic acid modified with hydrophobic vinyl monomers. HMHECs include hydroxyethyl cellulose modified with hydrophobic alkyl chains. Hydrophobically modified polyacrylamides include copolymers of acrylamide with acrylamide modified with hydrophobic alkyl chains (N-alkyl acrylamide). In certain embodiments, the coating composition includes a hydrophobically modified hydroxyethyl cellulose thickener.
Defoamers serve to minimize frothing during mixing and/or application of the coating composition. Suitable defoamers include organic defoamers such as mineral oils, silicone oils, and silica-based defoamers. Exemplary silicone oils include polysiloxanes, polydimethylsiloxanes, polyether modified polysiloxanes, and combinations thereof. Exemplary defoamers include BYK®-035, available from BYK USA Inc., the TEGO® series of defoamers, available from Evonik Industries, the DREWPLUS® series of defoamers, available from Ashland Inc., and FOAMASTER® NXZ, available from BASF Corporation.
Suitable surfactants include nonionic surfactants and anionic surfactants. Examples of nonionic surfactants are alkylphenoxy polyethoxyethanols having alkyl groups of about 7 to about 18 carbon atoms, and having from about 6 to about 60 oxyethylene units; ethylene oxide derivatives of long chain carboxylic acids; analogous ethylene oxide condensates of long chain alcohols, and combinations thereof. Exemplary anionic surfactants include ammonium, alkali metal, alkaline earth metal, and lower alkyl quaternary ammonium salts of sulfosuccinates, higher fatty alcohol sulfates, aryl sulfonates, alkyl sulfonates, alkylaryl sulfonates, and combinations thereof. In certain embodiments, the composition comprises a nonionic alkylpolyethylene glycol surfactant, such as LUTENSOL® TDA 8 or LUTENSOL® AT-18, commercially available from BASF SE. In certain embodiments, the composition comprises an anionic alkyl ether sulfate surfactant, such as DISPONIL® FES 77, commercially available from BASF SE. In certain embodiments, the composition comprises an anionic diphenyl oxide disulfonate surfactant, such as CALFAX® DB-45, commercially available from Pilot Chemical.
Optionally, the coating compositions can further include quick setting additives. Exemplary quick setting additives suitable for use in the coating compositions described herein includes polyamines (i.e., polymers formed from either an amine-group containing monomer or an imine monomer as polymerized units such as aminoalkyl vinyl ether or sulfides; acrylamide or acrylic esters, such as dimethylaminoethyl(meth)acrylate; N-(meth)acryloxyalkyl-oxazolidines such as poly(oxazolidinylethyl methacrylate), N-(meth)acryloxyalkyltetrahydro-1,3-oxazines, and monomers that readily generate amines by hydrolysis). Suitable polyamines can include, for example, poly(oxazolidinylethyl methacrylate), poly(vinylamine), or polyalkyleneimine (e.g., polyethyleneimine). In some embodiments, the quick setting additive is a derivatized polyamine such as an alkoxylated polyalkyleneimine (e.g., ethoxylated polyethyleneimine). Suitable derivatized polyamines are described in U.S. Application Ser. No. 61/714,497, filed Oct. 16, 2012, which is incorporated by reference herein in its entirety.
Other suitable additives that can optionally be incorporated into the composition include coalescing agents (coalescents), pH modifying agents, biocides, co-solvents and plasticizers, crosslinking agents, dispersing agents, rheology modifiers, wetting and spreading agents, leveling agents, conductivity additives, adhesion promoters, anti-blocking agents, anti-cratering agents and anti-crawling agents, anti-freezing agents, corrosion inhibitors, anti-static agents, flame retardants and intumescent additives, dyes, optical brighteners and fluorescent additives, UV absorbers and light stabilizers, chelating agents, cleanability additives, flatting agents, flocculants, humectants, insecticides, lubricants, odorants, oils, waxes and slip aids, soil repellants, stain resisting agents, and combinations thereof.
Suitable coalescents, which aid in film formation during drying, include ethylene glycol monomethyl ether, ethylene glycol monobutyl ether, ethylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether acetate, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether acetate, dipropylene glycol monomethyl ether, 2,2,4-trimethyl-1,3-pentanediol monoisobutyrate, and combinations thereof.
Examples of suitable pH modifying agents include bases such as sodium hydroxide, potassium hydroxide, amino alcohols, monoethanolamine (MEA), diethanolamine (DEA), 2-(2-aminoethoxyl)ethanol, diisopropanolamine (DIPA), 1-amino-2-propanol (AMP), ammonia, and combinations thereof.
Suitable biocides can be incorporated to inhibit the growth of bacteria and other microbes in the coating composition during storage. Exemplary biocides include 2-[(hydroxymethyl)amino]ethanol, 2-[(hydroxymethyl)amino]2-methyl-1-propanol, o-phenylphenol, sodium salt, 1,2-benzisothiazolin-3-one, 2-methyl-4-isothiazolin-3-one (MIT), 5-chloro2-methyland-4-isothiazolin-3-one (CIT), 2-octyl-4-isothiazolin-3-one (OTT), 4,5-dichloro-2-n-octyl-3-isothiazolone, as well as acceptable salts and combinations thereof. Suitable biocides also include biocides that inhibit the growth of mold, mildew, and spores thereof in the coating. Examples of mildewcides include 2-(thiocyanomethylthio)benzothiazole, 3-iodo-2-propynyl butyl carbamate, 2,4,5,6-tetrachloroisophthalonitrile, 2-(4-thiazolyl)benzimidazole, 2-N-octyl4-isothiazolin-3-one, diiodomethyl p-tolyl sulfone, as well as acceptable salts and combinations thereof. In certain embodiments, the coating composition contains 1,2-benzisothiazolin-3-one or a salt thereof. Biocides of this type include PROXEL® BD20, commercially available from Arch Chemicals, Inc. The biocide can alternatively be applied as a film to the coating and a commercially available film-forming biocide is Zinc Omadine® commercially available from Arch Chemicals, Inc.
Exemplary co-solvents and humectants include ethylene glycol, propylene glycol, diethylene glycol, and combinations thereof.
Exemplary crosslinking agents include dihydrazides (e.g., dihydrazides of adipic acid, succinic acid, oxalic acid, glutamic acid, or sebastic acid). The dihydrazides can be used, for example, to crosslink diacetone acrylamide or other crosslinkable monomers.
A coating composition can be produced by combining the components as described herein. The resulting coating compositions can have a viscosity of from 12,000 to 85,000 cps at 25° C. For example, the coating compositions can have a viscosity of from 15,000 to 80,000 cps, 20,000 to 75,000 cps, 25,000 to 70,000 cps, 30,000 to 65,000 cps, 35,000 to 60,000 cps, or 40,000 to 55,000 cps at 25° C.
The volume solids percentage of the coating composition can be greater than 50%. For example, the volume solids percentage of the coating composition can be greater than 55%, greater than 60%, greater than 65%, greater than 70%, or greater than 75%.
Optionally, the weight solids percentage of the coating composition can be greater than 60%. For example, the weight solids percentage can be greater than 65%, greater than 70%, greater than 75%, or greater than 80%.
In some embodiments, the coating composition can include the following components (based on total weight of the coating composition): water 6.8-17.2% by weight, propylene glycol 0.5-2.5% by weight, pigment dispersing agent 0.4-0.85% by weight, copolymer dispersion (at 55-65% by weight copolymer) 37.8-41.3% by weight, plasticizer 0-1.0% by weight, defoamer 0.3-1.4% by weight, non-ionic surfactant 0-0.1% by weight, thickener 0.1-0.4% by weight, titanium dioxide 3.0-11.2% by weight, zinc oxide 0-3.4% by weight, calcium carbonate 27.7-33.7% by weight, talc or kaolin 0-18.3% by weight, biocide 0.1-0.3% by weight, and ammonia 0.1-0.3% by weight.
The coating composition can be applied to a substrate (e.g., as a film) and allowed to dry to form a dried coating. Generally, coatings are formed by applying a coating composition described herein to a surface, and allowing the coating to dry to form a dried coating. In some embodiments, the surface can be a substantially horizontal surface such as a roof surface. In some embodiments, the surface can be a substantially vertical surface such as a wall. Optionally, the coating composition can be applied to floors to provide moisture control to provide crack-bridging properties.
The coating composition can be applied to a surface by any suitable coating technique, including spraying, rolling, brushing, or spreading. Coating compositions can be applied in a single coat, or in multiple sequential coats (e.g., in two coats or in three coats) as required for a particular application. Generally, the coating composition is allowed to dry under ambient conditions. However, in certain embodiments, the coating composition can be dried, for example, by heating and/or by circulating air over the coating.
The coating can be co-applied with a setting accelerator to decrease the setting time of the coating on a surface. Suitable setting accelerators include compounds, such as acids, which consume the volatile base and decrease coating setting time. For example, the setting accelerator can be a dilute acid, such as acetic acid or citric acid. Setting accelerators can be applied to a surface prior to coating application, applied simultaneously with the coating composition, or applied to the coating after it has been applied to a surface but prior to drying.
The coating thickness can vary depending upon the application of the coating. For example, the coating can have a dry thickness of at least 10 mils (e.g., at least 15 mils, at least 20 mils, at least 25 mils, at least 30 mils, or at least 40 mils). In some instances, the coating has a dry thickness of less than 100 mils (e.g., less than 90 mils, less than 80 mils, less than 75 mils, less than 60 mils, less than 50 mils, less than 40 mils, less than 35 mils, or less than 30 mils). In some embodiments, the coating has a dry thickness of between 10 mils and 100 mils. In certain embodiments, the coating has a dry thickness of between 10 mils and 40 mils.
The coating composition can be applied as a film, dried, subjected to an accelerated weathering process to simulate extended field exposure for 1000 hours or more, and then subjected to the mandrel bend test set forth in ASTM D 6083-05 at −26° C. The coating composition described herein when applied as a film, dried and weathered passes the mandrel bend test set forth in ASTM D 6083-05 at −26° C. The dried and weathered coating compositions can have a tensile strength of from 200 psi or greater as set forth in ASTM D 6083-05. For example, the tensile strength of the dried and weathered coating compositions can be 250 psi or greater, 300 psi or greater, 350 psi or greater, or 400 psi or greater. Such dried and weathered coating compositions can also have an elongation at break of greater than 100% (e.g., greater than 200%, greater than 300%, or greater than 400%) as set forth in ASTM D 6083-05.
The examples below are intended to further illustrate certain aspects of the methods and compositions described herein, and are not intended to limit the scope of the claims.
Acrylic Copolymer Blends
An aqueous dispersion of acrylic copolymers was prepared by combining two copolymer dispersions, each separately prepared by emulsion polymerization. Exemplary ingredients used to prepare the coating compositions described herein are shown in Table 1.
The ingredients were mixed in the order shown in Table 1 until a homogeneous mixture was formed. The viscosities of the resulting mixtures were in the range of 12,000 to 85,000 cps at 25° C. The percentages of PVC in the mixtures were approximately 42%. The volume percentages of solids in the mixtures were approximately 59%.
Performance Properties of Comparative Example 1 and Example 5
Example 5 was prepared using 20 weight percent of D1 and 80 weight percent of D2. D1 is an acrylic copolymer containing diacetone acrylamide and adipic dihydrazide (DAAM/ADDH) room temperature crosslinking package and having a Tg of −28° C. D2 is a styrene-acrylate copolymer containing a silane crosslinker and having a Tg of −8° C. The dispersion was combined with additives listed in Table 1 to form a coating composition. The coating composition was applied as a film, dried, and weathered for 1278 hours. The resulting weathered film had a tensile strength of 390 psi, a 443% elongation at break, and a water absorption of 13.4%. The weathered film also passed the −26° C. mandrel bend test set forth in ASTM D 6083-05. A film prepared from D2 as the only copolymer (Comparative Example 1) and including the same additives in the same amounts as Example 5 failed the mandrel bend test after weathering and under similar conditions.
Example 6 was the same as Example 5 except it used 35 weight percent of D1 and 65 weight percent of D2 as described above. The resulting weathered film had a tensile strength of 354 psi, a 387% elongation at break, and a water absorption of 13.2%. The film of Example 6 also passed the −26° C. mandrel bend test set forth in ASTM D 6083-05.
Example 7 was the same as Example 5 except it used 50 weight percent of D1 and 50 weight percent of D2 as described above. The resulting weathered film had a tensile strength of 344 psi, a 388% elongation at break, and a water absorption of 13.6%. The film of Example 7 also passed the −26° C. mandrel bend test set forth in ASTM D 6083-05.
The compositions, products, and methods of the appended claims are not limited in scope by the specific compositions, products, and methods described herein, which are intended as illustrations of a few aspects of the claims and any compositions, products, and methods that are functionally equivalent are intended to fall within the scope of the claims. Various modifications of the compositions, products, and methods in addition to those shown and described herein are intended to fall within the scope of the appended claims. Further, while only certain representative composition materials and method steps disclosed herein are specifically described, other combinations of the composition materials and method steps also are intended to fall within the scope of the appended claims, even if not specifically recited. Thus, a combination of steps, elements, components, or constituents may be explicitly mentioned herein; however, other combinations of steps, elements, components, and constituents are included, even though not explicitly stated. The term “comprising” and variations thereof as used herein is used synonymously with the term “including” and variations thereof and are open, non-limiting terms. Although the terms “comprising” and “including” have been used herein to describe various embodiments, the terms “consisting essentially of” and “consisting of” can be used in place of “comprising” and “including” to provide for more specific embodiments of the invention and are also disclosed.
This application claims the benefit of U.S. Provisional Application No. 61/754,241 filed Jan. 18, 2013, the disclosure of which is hereby incorporated by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2014/050197 | 1/8/2014 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/111292 | 7/24/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3549566 | Mesirov | Dec 1970 | A |
4826907 | Murao | May 1989 | A |
5219914 | Warburton, Jr. | Jun 1993 | A |
5256746 | Blankenship et al. | Oct 1993 | A |
5258423 | Crabb et al. | Nov 1993 | A |
5260131 | Fukui et al. | Nov 1993 | A |
5260350 | Wright | Nov 1993 | A |
5260400 | Karydas | Nov 1993 | A |
5262474 | Minnis et al. | Nov 1993 | A |
5262476 | Laughner | Nov 1993 | A |
5264475 | Kissel | Nov 1993 | A |
5264510 | Swift et al. | Nov 1993 | A |
5266646 | Eisenhart et al. | Nov 1993 | A |
5268417 | Filges et al. | Dec 1993 | A |
5268419 | Stack et al. | Dec 1993 | A |
5268437 | Holy et al. | Dec 1993 | A |
5270046 | Sakamoto et al. | Dec 1993 | A |
5270358 | Asmus | Dec 1993 | A |
5270389 | Clouet | Dec 1993 | A |
5270414 | Saito et al. | Dec 1993 | A |
5273706 | Laughner | Dec 1993 | A |
5274006 | Kagoshima et al. | Dec 1993 | A |
5276090 | Hallden-Abberton | Jan 1994 | A |
5276092 | Kempner et al. | Jan 1994 | A |
5278222 | Stack | Jan 1994 | A |
5278225 | Kohlhammer et al. | Jan 1994 | A |
5278271 | Miyajima et al. | Jan 1994 | A |
5279898 | Evans et al. | Jan 1994 | A |
5280073 | Siol et al. | Jan 1994 | A |
5288807 | Hinz | Feb 1994 | A |
5288828 | Harris et al. | Feb 1994 | A |
5290855 | Kodama et al. | Mar 1994 | A |
5294686 | Fiarman et al. | Mar 1994 | A |
5294688 | Rehmer et al. | Mar 1994 | A |
5296530 | Bors et al. | Mar 1994 | A |
5298554 | Rehmer et al. | Mar 1994 | A |
5298585 | McCallum et al. | Mar 1994 | A |
5300288 | Albright | Apr 1994 | A |
5300570 | Ilenda et al. | Apr 1994 | A |
5302592 | Osei-Gyimah et al. | Apr 1994 | A |
5304707 | Blankenship et al. | Apr 1994 | A |
5306762 | Hutter | Apr 1994 | A |
5308894 | Laughner | May 1994 | A |
5310810 | Natoli et al. | May 1994 | A |
5310816 | Pennington et al. | May 1994 | A |
5314943 | Steinwand | May 1994 | A |
5316860 | Stewart et al. | May 1994 | A |
5318719 | Hughes et al. | Jun 1994 | A |
5319031 | Hamilton et al. | Jun 1994 | A |
5320905 | Vaughn et al. | Jun 1994 | A |
5321056 | Carson et al. | Jun 1994 | A |
5322663 | Lai et al. | Jun 1994 | A |
5324456 | Degraff | Jun 1994 | A |
5326843 | Lorah et al. | Jul 1994 | A |
5328952 | Brodnyan et al. | Jul 1994 | A |
5328972 | Dada et al. | Jul 1994 | A |
5331018 | McGinniss et al. | Jul 1994 | A |
5332782 | Liu et al. | Jul 1994 | A |
5334450 | Zabrocki et al. | Aug 1994 | A |
5336720 | Richards et al. | Aug 1994 | A |
5338490 | Dietz et al. | Aug 1994 | A |
5338803 | Sun et al. | Aug 1994 | A |
5340858 | Bauer et al. | Aug 1994 | A |
5340871 | Pearson et al. | Aug 1994 | A |
5342884 | Tabor et al. | Aug 1994 | A |
5342899 | Graham et al. | Aug 1994 | A |
5342904 | Hefner et al. | Aug 1994 | A |
5342910 | Kling et al. | Aug 1994 | A |
5344868 | Hallden-Abberton et al. | Sep 1994 | A |
5346961 | Shaw et al. | Sep 1994 | A |
5348807 | Hodder et al. | Sep 1994 | A |
5348992 | Pearson et al. | Sep 1994 | A |
5348997 | Kato et al. | Sep 1994 | A |
5349025 | Siol et al. | Sep 1994 | A |
5352516 | Therriault et al. | Oct 1994 | A |
5356616 | Sojka et al. | Oct 1994 | A |
5360826 | Egolf et al. | Nov 1994 | A |
5362816 | Snyder et al. | Nov 1994 | A |
5368761 | Gore et al. | Nov 1994 | A |
5369169 | La Fleur et al. | Nov 1994 | A |
5371112 | Sayre et al. | Dec 1994 | A |
5371179 | Paik et al. | Dec 1994 | A |
5374674 | Sojka et al. | Dec 1994 | A |
5374684 | Tai | Dec 1994 | A |
5374686 | Clikeman | Dec 1994 | A |
5376447 | Yeung et al. | Dec 1994 | A |
5378758 | Amici et al. | Jan 1995 | A |
5380782 | Bogan | Jan 1995 | A |
5380801 | Fischer et al. | Jan 1995 | A |
5384373 | McKinney et al. | Jan 1995 | A |
5387635 | Rowland et al. | Feb 1995 | A |
5387641 | Yeung et al. | Feb 1995 | A |
5389178 | Harvey | Feb 1995 | A |
5389437 | Miyajima et al. | Feb 1995 | A |
5389726 | Sojka | Feb 1995 | A |
5393795 | Hedstrand et al. | Feb 1995 | A |
5395471 | Obijeski et al. | Mar 1995 | A |
5395882 | Siol et al. | Mar 1995 | A |
5395905 | Creamer et al. | Mar 1995 | A |
5395907 | Zajaczowski | Mar 1995 | A |
5401695 | Wu | Mar 1995 | A |
5401807 | Hughes et al. | Mar 1995 | A |
5403875 | Bortnik et al. | Apr 1995 | A |
5403894 | Tsai et al. | Apr 1995 | A |
5403903 | Shimizu et al. | Apr 1995 | A |
5405670 | Wetzel et al. | Apr 1995 | A |
5408024 | Fischer et al. | Apr 1995 | A |
5409967 | Carson et al. | Apr 1995 | A |
5413660 | Harvey et al. | May 1995 | A |
5413731 | Adler et al. | May 1995 | A |
5414047 | Clikeman | May 1995 | A |
5416148 | Farah et al. | May 1995 | A |
5416160 | Johnson | May 1995 | A |
5419967 | LaFleur et al. | May 1995 | A |
5420223 | Johnson | May 1995 | A |
5424337 | Bedel et al. | Jun 1995 | A |
5424362 | Hwang et al. | Jun 1995 | A |
5426125 | Vo et al. | Jun 1995 | A |
5426156 | Bederke et al. | Jun 1995 | A |
5430089 | Harris et al. | Jul 1995 | A |
5430101 | Minematsu et al. | Jul 1995 | A |
5433984 | Ilenda et al. | Jul 1995 | A |
5439739 | Furukawa et al. | Aug 1995 | A |
5439998 | Lina et al. | Aug 1995 | A |
5442012 | Kempner et al. | Aug 1995 | A |
5451644 | Fiarman et al. | Sep 1995 | A |
RE35049 | Atherton et al. | Oct 1995 | E |
5455321 | Cummings et al. | Oct 1995 | A |
5457156 | Liu et al. | Oct 1995 | A |
5458980 | Larson | Oct 1995 | A |
5460818 | Park et al. | Oct 1995 | A |
5461092 | Laughner | Oct 1995 | A |
5461106 | Jialanella et al. | Oct 1995 | A |
5466756 | Roach et al. | Nov 1995 | A |
5468526 | Allen et al. | Nov 1995 | A |
5468800 | Foelsch et al. | Nov 1995 | A |
5470622 | Rinde et al. | Nov 1995 | A |
5470908 | Schmidt et al. | Nov 1995 | A |
5470918 | Tsutsumi et al. | Nov 1995 | A |
5473006 | Hutter et al. | Dec 1995 | A |
5473031 | Tinetti et al. | Dec 1995 | A |
5474855 | Antheunisse | Dec 1995 | A |
5475047 | Tonson et al. | Dec 1995 | A |
5480720 | Eisenhart et al. | Jan 1996 | A |
5484849 | Bors et al. | Jan 1996 | A |
5486949 | Schrenk et al. | Jan 1996 | A |
5491192 | Walker et al. | Feb 1996 | A |
5494508 | Vogel | Feb 1996 | A |
5494971 | Blankenship | Feb 1996 | A |
5494975 | LaVoie et al. | Feb 1996 | A |
5498659 | Esser | Mar 1996 | A |
5502089 | Bricker et al. | Mar 1996 | A |
5502106 | LaFleur et al. | Mar 1996 | A |
5503767 | Schwartz | Apr 1996 | A |
5504153 | Amici et al. | Apr 1996 | A |
5506282 | Min et al. | Apr 1996 | A |
5506307 | Memon | Apr 1996 | A |
5506324 | Gartner et al. | Apr 1996 | A |
5519063 | Mondet et al. | May 1996 | A |
5519064 | Stringfield et al. | May 1996 | A |
5520767 | Larson | May 1996 | A |
5521253 | Lee et al. | May 1996 | A |
5525651 | Ogoe et al. | Jun 1996 | A |
5527613 | Blankenship et al. | Jun 1996 | A |
5532307 | Bogan | Jul 1996 | A |
5534310 | Rokowski et al. | Jul 1996 | A |
5539054 | LaFleur | Jul 1996 | A |
5543448 | Laughner | Aug 1996 | A |
5545689 | Amici et al. | Aug 1996 | A |
5547756 | Kamo et al. | Aug 1996 | A |
5548024 | LaVoie et al. | Aug 1996 | A |
5559192 | Bors et al. | Sep 1996 | A |
5562953 | Bors et al. | Oct 1996 | A |
5562958 | Walton et al. | Oct 1996 | A |
5562983 | Kono et al. | Oct 1996 | A |
5567353 | Bogan | Oct 1996 | A |
5567488 | Allen et al. | Oct 1996 | A |
5567489 | Allen et al. | Oct 1996 | A |
5567789 | Manzouji et al. | Oct 1996 | A |
5567790 | Okawa | Oct 1996 | A |
5569687 | Sanborn et al. | Oct 1996 | A |
5569710 | LaFleur et al. | Oct 1996 | A |
5573994 | Kabra et al. | Nov 1996 | A |
5576378 | Kuhlmann et al. | Nov 1996 | A |
5578247 | McGinniss et al. | Nov 1996 | A |
5580650 | Forgach et al. | Dec 1996 | A |
5599854 | Troy et al. | Feb 1997 | A |
5599890 | Tang | Feb 1997 | A |
5604288 | Furukawa et al. | Feb 1997 | A |
5605722 | Esser | Feb 1997 | A |
5605953 | Esser | Feb 1997 | A |
5605960 | Brady et al. | Feb 1997 | A |
5612397 | Gebhard et al. | Mar 1997 | A |
5612413 | Rozkuszka et al. | Mar 1997 | A |
5612820 | Schrenk et al. | Mar 1997 | A |
5614582 | Hori et al. | Mar 1997 | A |
5616638 | Hallden-Abberton et al. | Apr 1997 | A |
5618900 | Drumright et al. | Apr 1997 | A |
5622997 | Tennison et al. | Apr 1997 | A |
5623004 | Bertram et al. | Apr 1997 | A |
5625001 | Makower et al. | Apr 1997 | A |
5629377 | Burgert et al. | May 1997 | A |
5633316 | Gartner et al. | May 1997 | A |
5633335 | Manzouji et al. | May 1997 | A |
5635574 | Aoyagi et al. | Jun 1997 | A |
5643993 | Guerin | Jul 1997 | A |
5652289 | Eisenhart et al. | Jul 1997 | A |
5652292 | Stanley | Jul 1997 | A |
5652293 | Eisenhart et al. | Jul 1997 | A |
5652305 | Amici et al. | Jul 1997 | A |
5652306 | Meyer et al. | Jul 1997 | A |
5654365 | Havriliak et al. | Aug 1997 | A |
5654366 | Furukawa et al. | Aug 1997 | A |
5658965 | Manzouji et al. | Aug 1997 | A |
5663213 | Jones et al. | Sep 1997 | A |
5663241 | Takamatsu et al. | Sep 1997 | A |
5663259 | Treybig et al. | Sep 1997 | A |
5672379 | Schall et al. | Sep 1997 | A |
5672656 | Murayama et al. | Sep 1997 | A |
5674934 | Schmidt et al. | Oct 1997 | A |
5674943 | Farah et al. | Oct 1997 | A |
5679732 | Van Rheenen | Oct 1997 | A |
5681880 | Desor et al. | Oct 1997 | A |
5686528 | Willis et al. | Nov 1997 | A |
5693704 | Estes | Dec 1997 | A |
5693716 | Bott et al. | Dec 1997 | A |
5700867 | Ishiyama et al. | Dec 1997 | A |
5700873 | Zajaczkowski et al. | Dec 1997 | A |
5700885 | Pham et al. | Dec 1997 | A |
5703157 | Fujiwara et al. | Dec 1997 | A |
5705560 | Takarabe et al. | Jan 1998 | A |
5710227 | Freeman et al. | Jan 1998 | A |
5712031 | Kelch et al. | Jan 1998 | A |
5714537 | Laughner et al. | Feb 1998 | A |
5717000 | Karande et al. | Feb 1998 | A |
5723182 | Choi et al. | Mar 1998 | A |
5731377 | Friel | Mar 1998 | A |
5731379 | Kennan et al. | Mar 1998 | A |
5741594 | Jialanella | Apr 1998 | A |
5744564 | Stanley et al. | Apr 1998 | A |
5750587 | Manzouji et al. | May 1998 | A |
5753766 | Bott et al. | May 1998 | A |
5755972 | Hann et al. | May 1998 | A |
5756659 | Hughes et al. | May 1998 | A |
5763012 | Zhao et al. | Jun 1998 | A |
5766908 | Klein et al. | Jun 1998 | A |
5767213 | Graham et al. | Jun 1998 | A |
5777034 | Shah et al. | Jul 1998 | A |
5783626 | Taylor et al. | Jul 1998 | A |
5786424 | Hofmeister et al. | Jul 1998 | A |
5804254 | Nedwick et al. | Sep 1998 | A |
5804632 | Haddleton et al. | Sep 1998 | A |
5817712 | Weinberger et al. | Oct 1998 | A |
5820993 | Schall et al. | Oct 1998 | A |
5821283 | Hesler et al. | Oct 1998 | A |
5821295 | Nakayama et al. | Oct 1998 | A |
5824762 | Saruyama et al. | Oct 1998 | A |
5837762 | Stollmaier et al. | Nov 1998 | A |
5837766 | Metro et al. | Nov 1998 | A |
5840428 | Blizzard et al. | Nov 1998 | A |
5846657 | Wu | Dec 1998 | A |
5856409 | Ziemelis et al. | Jan 1999 | A |
5856611 | Schlaefer et al. | Jan 1999 | A |
5859112 | Overbeek et al. | Jan 1999 | A |
5863999 | Kinker et al. | Jan 1999 | A |
5866664 | McCallum et al. | Feb 1999 | A |
5869590 | Clark et al. | Feb 1999 | A |
5869591 | McKay et al. | Feb 1999 | A |
5879759 | Zang | Mar 1999 | A |
5883188 | Hwang et al. | Mar 1999 | A |
5885746 | Iwai et al. | Mar 1999 | A |
5891950 | Collins et al. | Apr 1999 | A |
5900462 | Tanaka | May 1999 | A |
5910358 | Thoen et al. | Jun 1999 | A |
5910532 | Schmidt et al. | Jun 1999 | A |
5912293 | Stockwell et al. | Jun 1999 | A |
5916960 | Lum et al. | Jun 1999 | A |
5916967 | Jones et al. | Jun 1999 | A |
5919849 | Memon et al. | Jul 1999 | A |
5922410 | Swartz et al. | Jul 1999 | A |
5922789 | Kohlhammer et al. | Jul 1999 | A |
5928206 | Miyake et al. | Jul 1999 | A |
5928730 | Nakayama | Jul 1999 | A |
5929128 | Whetten et al. | Jul 1999 | A |
5929172 | Zajaczkowski | Jul 1999 | A |
5932350 | Lauer et al. | Aug 1999 | A |
5948874 | Pike et al. | Sep 1999 | A |
5959016 | Schmidt et al. | Sep 1999 | A |
5962545 | Chaudhary et al. | Oct 1999 | A |
5962556 | Taylor | Oct 1999 | A |
5962571 | Overbeek et al. | Oct 1999 | A |
5962609 | Haddleton et al. | Oct 1999 | A |
5969046 | Schindler et al. | Oct 1999 | A |
5969063 | Parker et al. | Oct 1999 | A |
5972363 | Clikeman et al. | Oct 1999 | A |
5977194 | Mork et al. | Nov 1999 | A |
5977271 | McKay et al. | Nov 1999 | A |
5977274 | Leblanc et al. | Nov 1999 | A |
5981642 | Overbeek et al. | Nov 1999 | A |
5981666 | Zajaczkowski et al. | Nov 1999 | A |
5986003 | Lee et al. | Nov 1999 | A |
5988455 | Pearson et al. | Nov 1999 | A |
5997952 | Harris et al. | Dec 1999 | A |
5997969 | Gardon | Dec 1999 | A |
5998514 | Cheng et al. | Dec 1999 | A |
5998543 | Collins et al. | Dec 1999 | A |
6005042 | Desor et al. | Dec 1999 | A |
6010783 | Tung | Jan 2000 | A |
6013732 | Yamana et al. | Jan 2000 | A |
6017721 | Butz | Jan 2000 | A |
6017848 | Mando et al. | Jan 2000 | A |
6025404 | Harris et al. | Feb 2000 | A |
6031047 | Brady et al. | Feb 2000 | A |
6040386 | Iliopoulo et al. | Mar 2000 | A |
6040409 | Lau et al. | Mar 2000 | A |
6051633 | Tomko et al. | Apr 2000 | A |
6057400 | Kinney et al. | May 2000 | A |
6060556 | Collins et al. | May 2000 | A |
6063823 | Nakatani et al. | May 2000 | A |
6072013 | Manzouji et al. | Jun 2000 | A |
6077527 | Tan et al. | Jun 2000 | A |
6084029 | McGee | Jul 2000 | A |
6084044 | Roe et al. | Jul 2000 | A |
6087425 | Eisenhart et al. | Jul 2000 | A |
6087447 | Stevens et al. | Jul 2000 | A |
6090875 | Staples et al. | Jul 2000 | A |
6090882 | Trumbo et al. | Jul 2000 | A |
6090902 | Kuo et al. | Jul 2000 | A |
6096669 | Colegrove et al. | Aug 2000 | A |
6113978 | Ornstein et al. | Sep 2000 | A |
6120638 | Baxter et al. | Sep 2000 | A |
6124370 | Walton et al. | Sep 2000 | A |
6136883 | Yang et al. | Oct 2000 | A |
6136896 | Lee et al. | Oct 2000 | A |
6140431 | Kinker et al. | Oct 2000 | A |
6143829 | Babb et al. | Nov 2000 | A |
6153690 | Larson et al. | Nov 2000 | A |
6160029 | Chaudhary et al. | Dec 2000 | A |
6160044 | Jimbo et al. | Dec 2000 | A |
6160057 | Webster et al. | Dec 2000 | A |
6168866 | Clark | Jan 2001 | B1 |
6183829 | Daecher et al. | Feb 2001 | B1 |
6184294 | Park et al. | Feb 2001 | B1 |
6187834 | Thayer et al. | Feb 2001 | B1 |
6191244 | Lau et al. | Feb 2001 | B1 |
6194525 | Ortiz et al. | Feb 2001 | B1 |
6197382 | Ornstein et al. | Mar 2001 | B1 |
6201067 | Cheung et al. | Mar 2001 | B1 |
6207780 | Stockhausen et al. | Mar 2001 | B1 |
6218464 | Parker et al. | Apr 2001 | B1 |
6218491 | Fu et al. | Apr 2001 | B1 |
6221448 | Baetzold et al. | Apr 2001 | B1 |
6225242 | Lau et al. | May 2001 | B1 |
6228201 | Cooper et al. | May 2001 | B1 |
6228901 | Brown et al. | May 2001 | B1 |
6228913 | Owens et al. | May 2001 | B1 |
6228949 | Webster et al. | May 2001 | B1 |
6232417 | Rhodes et al. | May 2001 | B1 |
6235814 | Bowe | May 2001 | B1 |
6238795 | Strom et al. | May 2001 | B1 |
6239209 | Yang et al. | May 2001 | B1 |
6239228 | Zajaczkowski et al. | May 2001 | B1 |
6242515 | Zhao et al. | Jun 2001 | B1 |
6242526 | Siddiqui et al. | Jun 2001 | B1 |
6242528 | Clark et al. | Jun 2001 | B1 |
6245711 | Halbrook | Jun 2001 | B1 |
6248826 | Solomon et al. | Jun 2001 | B1 |
6251213 | Bartman et al. | Jun 2001 | B1 |
6251485 | Harris et al. | Jun 2001 | B1 |
6251680 | Fu et al. | Jun 2001 | B1 |
6251973 | Robinson et al. | Jun 2001 | B1 |
6251988 | Blum et al. | Jun 2001 | B1 |
6254956 | Kjellqvist et al. | Jul 2001 | B1 |
6255381 | Park et al. | Jul 2001 | B1 |
6260715 | Simard et al. | Jul 2001 | B1 |
6262149 | Clark et al. | Jul 2001 | B1 |
6262161 | Betso et al. | Jul 2001 | B1 |
6262169 | Helmer et al. | Jul 2001 | B1 |
6265514 | Warren et al. | Jul 2001 | B1 |
6277437 | Helmer et al. | Aug 2001 | B1 |
6280808 | Fields et al. | Aug 2001 | B1 |
6291021 | Morita et al. | Sep 2001 | B1 |
6297328 | Collins et al. | Oct 2001 | B1 |
6300407 | Machleder et al. | Oct 2001 | B1 |
6300409 | Lau et al. | Oct 2001 | B2 |
6303186 | Bors et al. | Oct 2001 | B1 |
6303188 | Bors et al. | Oct 2001 | B1 |
6306962 | Pham et al. | Oct 2001 | B1 |
6306969 | Patel et al. | Oct 2001 | B1 |
6306991 | Fischer et al. | Oct 2001 | B1 |
6310112 | Vo et al. | Oct 2001 | B1 |
6310125 | Rayner | Oct 2001 | B1 |
6310159 | Eiffler et al. | Oct 2001 | B1 |
6322860 | Stein et al. | Nov 2001 | B1 |
6325939 | Strom et al. | Dec 2001 | B2 |
6326449 | Haldankar | Dec 2001 | B1 |
6331580 | Molnar | Dec 2001 | B1 |
6333378 | Clark et al. | Dec 2001 | B1 |
6335404 | Kirk et al. | Jan 2002 | B1 |
6337366 | Amick et al. | Jan 2002 | B1 |
6338801 | Strom et al. | Jan 2002 | B2 |
6344502 | Babjak et al. | Feb 2002 | B1 |
6346300 | Ruepping | Feb 2002 | B1 |
6348623 | Webster et al. | Feb 2002 | B2 |
6358620 | Yokelson et al. | Mar 2002 | B1 |
6359110 | Mussell et al. | Mar 2002 | B1 |
6361768 | Galleguillos et al. | Mar 2002 | B1 |
6362274 | Legrand et al. | Mar 2002 | B1 |
6368575 | Chang et al. | Apr 2002 | B2 |
6369182 | Whipple et al. | Apr 2002 | B1 |
6372831 | Sikkema et al. | Apr 2002 | B1 |
6372871 | Jimbo et al. | Apr 2002 | B1 |
6376574 | Helmer et al. | Apr 2002 | B1 |
6376600 | Solomon et al. | Apr 2002 | B1 |
6380303 | Ogoe et al. | Apr 2002 | B1 |
6380304 | Vanspeybroeck et al. | Apr 2002 | B1 |
6383569 | Ornstein et al. | May 2002 | B2 |
6384104 | Chang et al. | May 2002 | B1 |
6384131 | Kinney et al. | May 2002 | B1 |
6387167 | Haldankar | May 2002 | B1 |
6395813 | Duccini et al. | May 2002 | B1 |
6395836 | Shinoda | May 2002 | B1 |
6399171 | Merlin et al. | Jun 2002 | B1 |
6417267 | Stockl et al. | Jul 2002 | B1 |
6419830 | Strom et al. | Jul 2002 | B2 |
6423382 | Bowe et al. | Jul 2002 | B1 |
6423416 | Nanavati | Jul 2002 | B1 |
6423805 | Bacho et al. | Jul 2002 | B1 |
6433058 | Weir et al. | Aug 2002 | B1 |
6433098 | Brown et al. | Aug 2002 | B1 |
6436421 | Schindler et al. | Aug 2002 | B1 |
6436498 | Rangwalla et al. | Aug 2002 | B1 |
6441082 | Weitzel et al. | Aug 2002 | B1 |
6444749 | Mestach | Sep 2002 | B2 |
6447845 | Nanavati et al. | Sep 2002 | B1 |
6451403 | Daecher et al. | Sep 2002 | B1 |
6451899 | Zhao et al. | Sep 2002 | B1 |
6451912 | Kelch | Sep 2002 | B1 |
6451951 | Beckley et al. | Sep 2002 | B2 |
6455161 | Regnier et al. | Sep 2002 | B1 |
6458458 | Cooke et al. | Oct 2002 | B1 |
6458878 | Tsuboi et al. | Oct 2002 | B1 |
6465558 | Scheibelhoffer et al. | Oct 2002 | B2 |
6465563 | Mori et al. | Oct 2002 | B1 |
6471885 | Chiang et al. | Oct 2002 | B2 |
6472452 | Ruepping | Oct 2002 | B2 |
6475556 | Sobczak et al. | Nov 2002 | B1 |
6476168 | Dahanayake et al. | Nov 2002 | B1 |
6479571 | Cooke et al. | Nov 2002 | B1 |
6482502 | Fields et al. | Nov 2002 | B1 |
6482886 | Finlayson et al. | Nov 2002 | B1 |
6489381 | Dreher et al. | Dec 2002 | B1 |
6489385 | Fujii et al. | Dec 2002 | B1 |
6492445 | Siddiqui et al. | Dec 2002 | B2 |
6492450 | Hsu | Dec 2002 | B1 |
6503992 | Mitchell et al. | Jan 2003 | B2 |
6514584 | Merlin et al. | Feb 2003 | B1 |
6515041 | Hayashi et al. | Feb 2003 | B2 |
6515042 | Kriessmann et al. | Feb 2003 | B2 |
6515082 | Brown et al. | Feb 2003 | B1 |
6518348 | Lee et al. | Feb 2003 | B1 |
6521696 | Oates et al. | Feb 2003 | B2 |
6525161 | Hall | Feb 2003 | B1 |
6528581 | Kelly et al. | Mar 2003 | B1 |
6528593 | Eiffler et al. | Mar 2003 | B1 |
6534592 | Chou et al. | Mar 2003 | B1 |
6538062 | Sakaguchi et al. | Mar 2003 | B2 |
6541088 | Rangwalla et al. | Apr 2003 | B1 |
6541571 | Haldankar | Apr 2003 | B1 |
6548596 | Kohr et al. | Apr 2003 | B1 |
6552129 | Babb et al. | Apr 2003 | B2 |
6555641 | Parker et al. | Apr 2003 | B2 |
6558688 | Saishin et al. | May 2003 | B2 |
6558809 | Kelch et al. | May 2003 | B1 |
6559193 | Nonoyama et al. | May 2003 | B2 |
6559231 | Hasegawa et al. | May 2003 | B2 |
6566466 | Zajaczkowski | May 2003 | B1 |
6566469 | Kaplan et al. | May 2003 | B1 |
6569976 | Baxter et al. | May 2003 | B2 |
6572965 | McGee et al. | Jun 2003 | B1 |
6579958 | Wilson | Jun 2003 | B2 |
6586097 | Pascault et al. | Jul 2003 | B1 |
6586501 | Dalton et al. | Jul 2003 | B1 |
6586512 | Dukes et al. | Jul 2003 | B1 |
6590006 | Park et al. | Jul 2003 | B2 |
6593399 | La Fleur et al. | Jul 2003 | B1 |
6602557 | Ruepping | Aug 2003 | B2 |
6605359 | Robinson et al. | Aug 2003 | B2 |
6610282 | Ghosh | Aug 2003 | B1 |
6613827 | Lundgard et al. | Sep 2003 | B2 |
6617267 | Soane et al. | Sep 2003 | B2 |
6620474 | Regnier et al. | Sep 2003 | B1 |
6624212 | Weier et al. | Sep 2003 | B2 |
6627670 | Mork et al. | Sep 2003 | B2 |
6627679 | Kling | Sep 2003 | B1 |
6630533 | Konopka et al. | Oct 2003 | B2 |
6632861 | Weitzel et al. | Oct 2003 | B1 |
6632879 | Brann et al. | Oct 2003 | B2 |
6632906 | Kamiyama | Oct 2003 | B1 |
6639012 | Wills et al. | Oct 2003 | B2 |
6642335 | Kawase et al. | Nov 2003 | B2 |
6646058 | Koger | Nov 2003 | B1 |
6646082 | Ghosh et al. | Nov 2003 | B2 |
6646086 | Slone | Nov 2003 | B2 |
6646091 | Taylor et al. | Nov 2003 | B2 |
6656979 | Kitano et al. | Dec 2003 | B1 |
6657011 | Lau et al. | Dec 2003 | B2 |
6657014 | Mori et al. | Dec 2003 | B1 |
6660394 | Ishizuki et al. | Dec 2003 | B1 |
6663974 | Kelch et al. | Dec 2003 | B2 |
6664327 | Daisey et al. | Dec 2003 | B2 |
6669953 | Kamiyama | Dec 2003 | B1 |
6670419 | Lau et al. | Dec 2003 | B2 |
6683120 | Munro et al. | Jan 2004 | B2 |
6683132 | Schick et al. | Jan 2004 | B1 |
6686008 | Merlin et al. | Feb 2004 | B1 |
6686321 | Boden et al. | Feb 2004 | B2 |
6689200 | Scarborough et al. | Feb 2004 | B2 |
6691715 | Matz et al. | Feb 2004 | B2 |
6693151 | Throne et al. | Feb 2004 | B2 |
6703433 | Bahadur et al. | Mar 2004 | B1 |
6706216 | Malz et al. | Mar 2004 | B1 |
6706217 | Malz et al. | Mar 2004 | B2 |
6706779 | Bahadur et al. | Mar 2004 | B2 |
6706818 | Ishihara et al. | Mar 2004 | B2 |
6710128 | Helmer et al. | Mar 2004 | B1 |
6716912 | Freeman et al. | Apr 2004 | B2 |
6716929 | Wilson | Apr 2004 | B2 |
6723486 | Goodall et al. | Apr 2004 | B2 |
6723764 | Sakabe | Apr 2004 | B2 |
6723775 | Lau et al. | Apr 2004 | B2 |
6727314 | Burghart et al. | Apr 2004 | B2 |
6730718 | Jakob | May 2004 | B1 |
6730734 | Hamilton et al. | May 2004 | B1 |
6730740 | Mestach et al. | May 2004 | B1 |
6740358 | Speece et al. | May 2004 | B2 |
6743844 | Tabor et al. | Jun 2004 | B1 |
6753355 | Stollmaier et al. | Jun 2004 | B2 |
6756075 | DeMasi et al. | Jun 2004 | B2 |
6756459 | Larson et al. | Jun 2004 | B2 |
6759463 | Lorah et al. | Jul 2004 | B2 |
6759484 | Murayama et al. | Jul 2004 | B1 |
6762241 | Blum et al. | Jul 2004 | B1 |
6765049 | Lorah et al. | Jul 2004 | B2 |
6767931 | Martinez et al. | Jul 2004 | B2 |
6770285 | Keenan et al. | Aug 2004 | B2 |
6784239 | Wada et al. | Aug 2004 | B2 |
6794042 | Merlin et al. | Sep 2004 | B1 |
6803390 | Lekovic et al. | Oct 2004 | B2 |
6812309 | Clark | Nov 2004 | B2 |
6812366 | Lin | Nov 2004 | B2 |
6815475 | Donald et al. | Nov 2004 | B2 |
6818684 | Slone | Nov 2004 | B2 |
6844065 | Reddy et al. | Jan 2005 | B2 |
6846564 | Pascault et al. | Jan 2005 | B1 |
6848777 | Chen et al. | Feb 2005 | B2 |
6849681 | Hutter et al. | Feb 2005 | B2 |
6852819 | Ohnishi et al. | Feb 2005 | B2 |
6858299 | Lundquist et al. | Feb 2005 | B2 |
6861475 | Ilenda et al. | Mar 2005 | B2 |
6864309 | Lau et al. | Mar 2005 | B2 |
6869996 | Krajnik et al. | Mar 2005 | B1 |
6870011 | MacQueen et al. | Mar 2005 | B2 |
6875797 | Redlich et al. | Apr 2005 | B2 |
6875820 | Berard et al. | Apr 2005 | B2 |
6878776 | Pascault et al. | Apr 2005 | B1 |
6884468 | Abundis et al. | Apr 2005 | B1 |
6884843 | Kauffman et al. | Apr 2005 | B2 |
6887574 | Dean et al. | May 2005 | B2 |
6887960 | Parker et al. | May 2005 | B2 |
6893722 | McGee | May 2005 | B2 |
6900249 | Mork et al. | May 2005 | B2 |
6914091 | Donald et al. | Jul 2005 | B2 |
6914095 | Lorah et al. | Jul 2005 | B2 |
6914099 | Kim | Jul 2005 | B2 |
6919400 | Nungesser et al. | Jul 2005 | B2 |
6924011 | Aert et al. | Aug 2005 | B2 |
6931809 | Brown et al. | Aug 2005 | B1 |
6939922 | Beckley et al. | Sep 2005 | B2 |
6943231 | Bühler | Sep 2005 | B2 |
6951598 | Flugge et al. | Oct 2005 | B2 |
6953501 | Herbert et al. | Oct 2005 | B2 |
6967227 | Hutter | Nov 2005 | B1 |
6969756 | Brennan et al. | Nov 2005 | B2 |
6982288 | Mitra et al. | Jan 2006 | B2 |
6987151 | Gartner et al. | Jan 2006 | B2 |
6989191 | Weissgerber et al. | Jan 2006 | B2 |
6992121 | Peters et al. | Jan 2006 | B1 |
6998435 | Hungrige et al. | Feb 2006 | B1 |
7025825 | Pyzik et al. | Apr 2006 | B2 |
7025853 | Kesselmayer | Apr 2006 | B2 |
7071256 | Green | Jul 2006 | B2 |
7071260 | Kuropka | Jul 2006 | B1 |
7073671 | Charkoudian | Jul 2006 | B2 |
7077981 | Wehner et al. | Jul 2006 | B2 |
7101924 | Von Schmittou et al. | Sep 2006 | B2 |
7112616 | Takizawa et al. | Sep 2006 | B2 |
7115682 | Guo et al. | Oct 2006 | B2 |
7132468 | Tepe | Nov 2006 | B2 |
7132489 | Lee et al. | Nov 2006 | B2 |
7138139 | Gauthier et al. | Nov 2006 | B2 |
7150787 | Clamen et al. | Dec 2006 | B2 |
7159655 | Ke et al. | Jan 2007 | B2 |
7160957 | Kuriyama et al. | Jan 2007 | B2 |
7173074 | Mitra et al. | Feb 2007 | B2 |
7186769 | Von Schmittou et al. | Mar 2007 | B2 |
7186773 | Araki et al. | Mar 2007 | B2 |
7199180 | Simmons et al. | Apr 2007 | B1 |
7208544 | Kawase et al. | Apr 2007 | B2 |
7211613 | Lorah et al. | May 2007 | B2 |
7214728 | Kimpimaki et al. | May 2007 | B2 |
7214737 | Albalat Perez et al. | May 2007 | B2 |
7217443 | Bobsein et al. | May 2007 | B2 |
7220338 | Chen et al. | May 2007 | B2 |
7220802 | Julien et al. | May 2007 | B2 |
7226887 | Wehmeyer | Jun 2007 | B2 |
7226955 | Subramonian et al. | Jun 2007 | B2 |
7232862 | Odagawa et al. | Jun 2007 | B2 |
7238732 | Bamborough et al. | Jul 2007 | B2 |
7238742 | Weese et al. | Jul 2007 | B2 |
7244784 | Amick et al. | Jul 2007 | B2 |
7247694 | Stein et al. | Jul 2007 | B2 |
7253307 | Carlson et al. | Aug 2007 | B1 |
7256227 | Stone | Aug 2007 | B2 |
7259203 | Chou et al. | Aug 2007 | B2 |
7262242 | Gielens et al. | Aug 2007 | B2 |
7270180 | Ke et al. | Sep 2007 | B2 |
7271202 | Krabbenborg et al. | Sep 2007 | B2 |
7273842 | VanDyk et al. | Sep 2007 | B1 |
7285585 | Coyle et al. | Oct 2007 | B2 |
7285590 | Holub et al. | Oct 2007 | B2 |
7309729 | Weese et al. | Dec 2007 | B1 |
7312277 | Maes et al. | Dec 2007 | B2 |
7312292 | Ravikiran et al. | Dec 2007 | B2 |
7323078 | Berezuk et al. | Jan 2008 | B2 |
7323527 | Bohling et al. | Jan 2008 | B1 |
7329722 | Vaitkeviciene et al. | Feb 2008 | B2 |
7332540 | Theelen et al. | Feb 2008 | B2 |
7344811 | Michaleviciute et al. | Mar 2008 | B2 |
7347988 | Hu et al. | Mar 2008 | B2 |
7361710 | Thames et al. | Apr 2008 | B2 |
7364774 | Urscheler et al. | Apr 2008 | B2 |
7375096 | Davis et al. | May 2008 | B1 |
7393887 | Friedrich et al. | Jul 2008 | B2 |
7396561 | Rühe | Jul 2008 | B2 |
7396871 | Shoaf et al. | Jul 2008 | B2 |
7399810 | Creamer et al. | Jul 2008 | B2 |
7399818 | Bromm et al. | Jul 2008 | B2 |
7405169 | Lu | Jul 2008 | B2 |
7411008 | Tucker et al. | Aug 2008 | B2 |
7414091 | Chen et al. | Aug 2008 | B2 |
7417086 | Griffith et al. | Aug 2008 | B2 |
7425246 | Urscheler | Sep 2008 | B2 |
7445849 | Apitz et al. | Nov 2008 | B2 |
7452935 | Slone et al. | Nov 2008 | B2 |
7452952 | Kohr et al. | Nov 2008 | B2 |
7455892 | Goodwin et al. | Nov 2008 | B2 |
7459496 | Hsu et al. | Dec 2008 | B2 |
7470751 | Taylor et al. | Dec 2008 | B2 |
7479521 | Braun et al. | Jan 2009 | B2 |
7504466 | Devonport et al. | Mar 2009 | B2 |
7507436 | Nakano et al. | Mar 2009 | B2 |
7510623 | Lutz et al. | Mar 2009 | B2 |
7517591 | Miyoshi et al. | Apr 2009 | B2 |
7520559 | Vo et al. | Apr 2009 | B2 |
7521099 | Ochi et al. | Apr 2009 | B2 |
7521100 | Imaizumi et al. | Apr 2009 | B2 |
7521101 | Naisby et al. | Apr 2009 | B2 |
7531600 | Rey | May 2009 | B1 |
7534843 | Jialanella et al. | May 2009 | B2 |
7537802 | Rosano | May 2009 | B2 |
7538151 | Fernandes et al. | May 2009 | B2 |
7538153 | Bacher et al. | May 2009 | B2 |
7544401 | Dungworth et al. | Jun 2009 | B2 |
7547745 | Valette | Jun 2009 | B2 |
7557158 | VanRheenen | Jul 2009 | B2 |
7557235 | Lai et al. | Jul 2009 | B2 |
7557372 | Yang et al. | Jul 2009 | B2 |
7563836 | Pierni et al. | Jul 2009 | B2 |
7572840 | Kleijn et al. | Aug 2009 | B2 |
7572843 | Renz et al. | Aug 2009 | B2 |
7576157 | Pajerski | Aug 2009 | B2 |
7579081 | Brown | Aug 2009 | B2 |
7585915 | Jakob et al. | Sep 2009 | B2 |
7592412 | Cray et al. | Sep 2009 | B2 |
7608655 | Hunig et al. | Oct 2009 | B2 |
7612145 | Azimipour et al. | Nov 2009 | B2 |
7618693 | Dungworth et al. | Nov 2009 | B2 |
7625687 | Hu et al. | Dec 2009 | B2 |
7629414 | Bardman et al. | Dec 2009 | B2 |
7637961 | El A'mma et al. | Dec 2009 | B2 |
7638176 | Kasperchik et al. | Dec 2009 | B2 |
7638579 | Finch et al. | Dec 2009 | B2 |
7648034 | Charkoudian et al. | Jan 2010 | B2 |
7648767 | Fu et al. | Jan 2010 | B2 |
7678156 | Gross et al. | Mar 2010 | B2 |
7678433 | Ochi et al. | Mar 2010 | B2 |
7683110 | Schlesiger et al. | Mar 2010 | B2 |
7683131 | Goldacker et al. | Mar 2010 | B2 |
7687561 | Misiak | Mar 2010 | B1 |
7691942 | Bardman et al. | Apr 2010 | B2 |
7700703 | Hughes et al. | Apr 2010 | B2 |
7709555 | Stappers et al. | May 2010 | B2 |
7718731 | Cogordan et al. | May 2010 | B2 |
7723850 | Gallagher et al. | May 2010 | B2 |
7732506 | Wang et al. | Jun 2010 | B2 |
7732525 | Branston et al. | Jun 2010 | B2 |
7741401 | Harris et al. | Jun 2010 | B2 |
7741402 | Bobsein et al. | Jun 2010 | B2 |
7745546 | MacQueen et al. | Jun 2010 | B2 |
7754300 | Beyer et al. | Jul 2010 | B2 |
7759404 | Burgun et al. | Jul 2010 | B2 |
7767747 | Lind et al. | Aug 2010 | B2 |
7767770 | Han et al. | Aug 2010 | B2 |
7780744 | Shah et al. | Aug 2010 | B2 |
7790244 | Dungworth et al. | Sep 2010 | B2 |
7794565 | Shannon et al. | Sep 2010 | B2 |
7803864 | Bobsein et al. | Sep 2010 | B2 |
7807271 | Branston et al. | Oct 2010 | B2 |
7807739 | Obst et al. | Oct 2010 | B2 |
7807765 | Ghosh et al. | Oct 2010 | B2 |
7820754 | Betremieux et al. | Oct 2010 | B2 |
7824746 | Imaizumi et al. | Nov 2010 | B2 |
7829611 | Kelly | Nov 2010 | B2 |
7829631 | Wu et al. | Nov 2010 | B2 |
7834087 | Joffre et al. | Nov 2010 | B2 |
7842755 | Morita et al. | Nov 2010 | B2 |
7847016 | Turek et al. | Dec 2010 | B2 |
7851575 | Ravikiran et al. | Dec 2010 | B2 |
7858197 | Ahn et al. | Dec 2010 | B2 |
7875355 | Rouge et al. | Jan 2011 | B2 |
7893157 | Troy et al. | Feb 2011 | B2 |
7893162 | Lafleur et al. | Feb 2011 | B2 |
7897689 | Harris et al. | Mar 2011 | B2 |
7906591 | Weinstein et al. | Mar 2011 | B2 |
7910663 | Taylor et al. | Mar 2011 | B2 |
7910680 | White et al. | Mar 2011 | B2 |
7914645 | Schalau et al. | Mar 2011 | B2 |
7923503 | Takahashi et al. | Apr 2011 | B2 |
7931963 | Maurer et al. | Apr 2011 | B2 |
7939169 | McGee et al. | May 2011 | B2 |
7947760 | Janmaat et al. | May 2011 | B2 |
7947776 | Moncla et al. | May 2011 | B2 |
7947790 | Katsurao et al. | May 2011 | B2 |
7951429 | Miller | May 2011 | B2 |
7951884 | Birkett et al. | May 2011 | B1 |
7955696 | Baikerikar et al. | Jun 2011 | B2 |
7955702 | Schwoeppe et al. | Jun 2011 | B2 |
7956132 | Arriola et al. | Jun 2011 | B2 |
7968619 | Cottrell et al. | Jun 2011 | B2 |
7968641 | Killilea | Jun 2011 | B2 |
7968650 | Tighe et al. | Jun 2011 | B2 |
7981327 | Sakaguchi et al. | Jul 2011 | B2 |
7981512 | Tamori et al. | Jul 2011 | B2 |
7981950 | O'Donnell et al. | Jul 2011 | B2 |
7985795 | Bobsein et al. | Jul 2011 | B2 |
7985809 | Krawczyk et al. | Jul 2011 | B2 |
7989082 | Vanrheenen | Aug 2011 | B2 |
7989505 | Hu et al. | Aug 2011 | B2 |
7998531 | Wevers et al. | Aug 2011 | B2 |
7999030 | Thames et al. | Aug 2011 | B2 |
7999040 | Patil et al. | Aug 2011 | B2 |
8007978 | Klier et al. | Aug 2011 | B2 |
8008396 | Rohrbach et al. | Aug 2011 | B2 |
8013058 | Ahn et al. | Sep 2011 | B2 |
8013068 | Beckley et al. | Sep 2011 | B2 |
8013092 | Krajnik et al. | Sep 2011 | B1 |
8025758 | Loehden et al. | Sep 2011 | B2 |
8034869 | Bobsein et al. | Oct 2011 | B2 |
8034871 | Bochnik et al. | Oct 2011 | B2 |
8043476 | Haigh et al. | Oct 2011 | B2 |
8048961 | Arriola et al. | Nov 2011 | B2 |
8053503 | Moncla et al. | Nov 2011 | B2 |
8058349 | Montoya-Goni et al. | Nov 2011 | B2 |
8062745 | McGee et al. | Nov 2011 | B2 |
8062994 | Masuda et al. | Nov 2011 | B2 |
8063128 | Moncla et al. | Nov 2011 | B2 |
8063143 | Morita et al. | Nov 2011 | B2 |
8071658 | Zhou et al. | Dec 2011 | B2 |
8080612 | Troy et al. | Dec 2011 | B2 |
8084543 | Lafleur et al. | Dec 2011 | B2 |
8088252 | Farwaha et al. | Jan 2012 | B2 |
8088547 | Hu et al. | Jan 2012 | B2 |
8092727 | Maurer et al. | Jan 2012 | B2 |
8124689 | Loubert et al. | Feb 2012 | B2 |
8128946 | Kawamura et al. | Mar 2012 | B2 |
8129442 | Ueyama et al. | Mar 2012 | B2 |
8133961 | Hsu et al. | Mar 2012 | B2 |
8133963 | Pierini et al. | Mar 2012 | B2 |
8137754 | Lai et al. | Mar 2012 | B2 |
8153721 | Balk et al. | Apr 2012 | B2 |
8158711 | Moncla et al. | Apr 2012 | B2 |
8158713 | Finegan et al. | Apr 2012 | B2 |
8163206 | Chang et al. | Apr 2012 | B2 |
8163837 | Moncla et al. | Apr 2012 | B2 |
8168736 | Schmitt et al. | May 2012 | B2 |
8178168 | O'Neill et al. | May 2012 | B2 |
8178600 | Kelly | May 2012 | B2 |
8178624 | Schultes et al. | May 2012 | B2 |
8192844 | Numrich et al. | Jun 2012 | B2 |
8193275 | Moncla et al. | Jun 2012 | B2 |
8193278 | Demarest et al. | Jun 2012 | B2 |
8198376 | Kobushi et al. | Jun 2012 | B2 |
8202946 | Patil et al. | Jun 2012 | B2 |
8207267 | Von Tschammer et al. | Jun 2012 | B2 |
8211982 | Harris et al. | Jul 2012 | B2 |
8227085 | Kishikawa et al. | Jul 2012 | B2 |
8227520 | Shirasaki et al. | Jul 2012 | B2 |
8227542 | Bardman et al. | Jul 2012 | B2 |
8227549 | Schultes et al. | Jul 2012 | B2 |
8232334 | Kelly et al. | Jul 2012 | B2 |
8232336 | Moncla et al. | Jul 2012 | B2 |
8236431 | Mukkamala | Aug 2012 | B2 |
8236975 | Hook et al. | Aug 2012 | B2 |
8252425 | Lee et al. | Aug 2012 | B2 |
8263679 | Zhou et al. | Sep 2012 | B2 |
8263720 | Salamone et al. | Sep 2012 | B1 |
8273822 | Rossi et al. | Sep 2012 | B2 |
8283404 | Allen et al. | Oct 2012 | B2 |
8299153 | Kelly | Oct 2012 | B2 |
8304485 | Allen et al. | Nov 2012 | B2 |
8304517 | Morimitsu et al. | Nov 2012 | B2 |
8304563 | Kruper et al. | Nov 2012 | B2 |
8308855 | Togashi et al. | Nov 2012 | B2 |
8309634 | Beyer et al. | Nov 2012 | B2 |
8309651 | Finch et al. | Nov 2012 | B2 |
8309669 | Schmitt et al. | Nov 2012 | B2 |
8313604 | Oshima et al. | Nov 2012 | B2 |
8324311 | Wasserman et al. | Dec 2012 | B2 |
8329797 | Eaton et al. | Dec 2012 | B2 |
8334021 | Hoefler et al. | Dec 2012 | B2 |
8334346 | Hibben | Dec 2012 | B2 |
8344046 | Tucker et al. | Jan 2013 | B2 |
8349929 | Kainz et al. | Jan 2013 | B2 |
8357749 | Malotky et al. | Jan 2013 | B2 |
8377852 | Ahn et al. | Feb 2013 | B2 |
8389113 | Ambrose et al. | Mar 2013 | B2 |
8404759 | Phelan | Mar 2013 | B2 |
8415404 | Nicolson et al. | Apr 2013 | B2 |
8415422 | Schuetz et al. | Apr 2013 | B2 |
8426637 | Koestner et al. | Apr 2013 | B2 |
8431229 | Schmitt et al. | Apr 2013 | B2 |
8440300 | Sharavanan et al. | May 2013 | B2 |
8470120 | Killat et al. | Jun 2013 | B2 |
8475878 | Claasen et al. | Jul 2013 | B2 |
8491729 | Bammel et al. | Jul 2013 | B2 |
8492465 | Seibold et al. | Jul 2013 | B2 |
8492472 | Elizalde et al. | Jul 2013 | B2 |
8492576 | Lai et al. | Jul 2013 | B2 |
8497337 | Herfert et al. | Jul 2013 | B2 |
8501832 | Tighe et al. | Aug 2013 | B2 |
8507622 | Lemonds et al. | Aug 2013 | B2 |
8513356 | Sharma et al. | Aug 2013 | B1 |
8519043 | Hartig et al. | Aug 2013 | B2 |
8524800 | Phelan | Sep 2013 | B2 |
8530362 | Nungesser et al. | Sep 2013 | B2 |
8530579 | Arriola et al. | Sep 2013 | B2 |
8530591 | Yang et al. | Sep 2013 | B2 |
8540358 | Mozel et al. | Sep 2013 | B2 |
8552119 | Hibben | Oct 2013 | B2 |
8557921 | Arriola et al. | Oct 2013 | B2 |
8580875 | Lee et al. | Nov 2013 | B2 |
8592518 | Bailey et al. | Nov 2013 | B2 |
8598369 | Hauck et al. | Dec 2013 | B2 |
8609759 | Fasano et al. | Dec 2013 | B2 |
8609779 | Harris et al. | Dec 2013 | B2 |
8609780 | Misiak et al. | Dec 2013 | B2 |
8609795 | Sugimoto et al. | Dec 2013 | B2 |
8641846 | Parsons et al. | Feb 2014 | B2 |
8648130 | Hasegawa et al. | Feb 2014 | B2 |
8658742 | Dombrowski et al. | Feb 2014 | B2 |
8697810 | Vogel et al. | Apr 2014 | B2 |
8703194 | Liu et al. | Apr 2014 | B2 |
8709543 | Lai et al. | Apr 2014 | B2 |
8710150 | Chang et al. | Apr 2014 | B2 |
8722787 | Romick et al. | May 2014 | B2 |
8733369 | Rees et al. | May 2014 | B2 |
8734817 | Hossainy et al. | May 2014 | B2 |
8741427 | Kim et al. | Jun 2014 | B2 |
8742016 | Besser et al. | Jun 2014 | B2 |
8747969 | Lu | Jun 2014 | B2 |
8765822 | Braun et al. | Jul 2014 | B2 |
8779051 | Kisin et al. | Jul 2014 | B2 |
8779053 | Lundgard et al. | Jul 2014 | B2 |
8790632 | Arthur | Jul 2014 | B2 |
8791190 | Pressley et al. | Jul 2014 | B2 |
8802238 | Zheng et al. | Aug 2014 | B2 |
20010044482 | Hu et al. | Nov 2001 | A1 |
20010056153 | Nakagome | Dec 2001 | A1 |
20020037956 | Avramidis et al. | Mar 2002 | A1 |
20020077435 | DeSimone et al. | Jun 2002 | A1 |
20020103278 | Krajnik et al. | Aug 2002 | A1 |
20020115795 | Shang et al. | Aug 2002 | A1 |
20020155235 | Taylor et al. | Oct 2002 | A1 |
20020168533 | Taylor et al. | Nov 2002 | A1 |
20030065068 | Inukai et al. | Apr 2003 | A1 |
20030139496 | Sugishima et al. | Jul 2003 | A1 |
20030147835 | Munro et al. | Aug 2003 | A1 |
20030158324 | Maxim | Aug 2003 | A1 |
20030224184 | Hermes et al. | Dec 2003 | A1 |
20030225183 | De Putter et al. | Dec 2003 | A1 |
20030232933 | Lagneaux et al. | Dec 2003 | A1 |
20040044124 | Hutter et al. | Mar 2004 | A1 |
20040054026 | Kunzler et al. | Mar 2004 | A1 |
20040054043 | Friedrich et al. | Mar 2004 | A1 |
20050075428 | Ddamulira et al. | Apr 2005 | A1 |
20050129769 | Barry et al. | Jun 2005 | A1 |
20050176874 | Panades et al. | Aug 2005 | A1 |
20050215746 | DeSimone et al. | Sep 2005 | A1 |
20050238884 | Peters et al. | Oct 2005 | A1 |
20050239957 | Pillsbury et al. | Oct 2005 | A1 |
20050288410 | Farcet | Dec 2005 | A1 |
20060004140 | Asano et al. | Jan 2006 | A1 |
20060069171 | Prokopowicz et al. | Mar 2006 | A1 |
20060079609 | Nishioka et al. | Apr 2006 | A1 |
20060089453 | Pajerski | Apr 2006 | A1 |
20060099347 | Sugeta et al. | May 2006 | A1 |
20060100352 | Arnold et al. | May 2006 | A1 |
20060135649 | Jedlicka et al. | Jun 2006 | A1 |
20060167206 | Maier et al. | Jul 2006 | A1 |
20060235124 | Wehner et al. | Oct 2006 | A1 |
20060247367 | Guo et al. | Nov 2006 | A1 |
20070027249 | Killilea | Feb 2007 | A1 |
20070032605 | Harashina | Feb 2007 | A1 |
20070055017 | Schultes et al. | Mar 2007 | A1 |
20070066777 | Bzowej et al. | Mar 2007 | A1 |
20070093575 | Murakami et al. | Apr 2007 | A1 |
20070129486 | Klein et al. | Jun 2007 | A1 |
20070142565 | Chaudhary et al. | Jun 2007 | A1 |
20070149641 | Goupil et al. | Jun 2007 | A1 |
20070149711 | Chaudhary et al. | Jun 2007 | A1 |
20070155862 | Haerzschel et al. | Jul 2007 | A1 |
20070173613 | Chaudhary et al. | Jul 2007 | A1 |
20070219315 | Braun | Sep 2007 | A1 |
20070238824 | Smak et al. | Oct 2007 | A1 |
20070238827 | Brady et al. | Oct 2007 | A1 |
20070244238 | Desor et al. | Oct 2007 | A1 |
20070265386 | Mallo et al. | Nov 2007 | A1 |
20070270065 | Bordes | Nov 2007 | A1 |
20070299180 | Joecken | Dec 2007 | A1 |
20070299242 | Faecke et al. | Dec 2007 | A1 |
20080014360 | Kim | Jan 2008 | A1 |
20080058473 | Freidzon et al. | Mar 2008 | A1 |
20080114125 | Bzowej et al. | May 2008 | A1 |
20080145564 | Allam et al. | Jun 2008 | A1 |
20080176968 | VanSumeren et al. | Jul 2008 | A1 |
20080262144 | Glockner et al. | Oct 2008 | A1 |
20080293848 | Tomko et al. | Nov 2008 | A1 |
20090054546 | Glockner et al. | Feb 2009 | A1 |
20090069491 | Costeux et al. | Mar 2009 | A1 |
20090075046 | Fox et al. | Mar 2009 | A1 |
20090111935 | Fujii et al. | Apr 2009 | A1 |
20090118416 | Nakamae et al. | May 2009 | A1 |
20090163635 | Raynolds et al. | Jun 2009 | A1 |
20090170973 | Mattiasson et al. | Jul 2009 | A1 |
20090264586 | Mestach et al. | Oct 2009 | A1 |
20100029857 | Soddemann et al. | Feb 2010 | A1 |
20100040668 | Riman et al. | Feb 2010 | A1 |
20100041820 | Eslinger et al. | Feb 2010 | A1 |
20100041821 | Eslinger et al. | Feb 2010 | A1 |
20100065498 | Charkoudian et al. | Mar 2010 | A1 |
20100065499 | Fernandez-Lahore et al. | Mar 2010 | A1 |
20100068541 | El A'mma et al. | Mar 2010 | A1 |
20100068958 | Carson et al. | Mar 2010 | A1 |
20100075043 | Kaimoto et al. | Mar 2010 | A1 |
20100075079 | Bernal-Lara et al. | Mar 2010 | A1 |
20100090372 | Ishikawa et al. | Apr 2010 | A1 |
20100093913 | Jones et al. | Apr 2010 | A1 |
20100129635 | Drzyzga et al. | May 2010 | A1 |
20100154146 | Shah et al. | Jun 2010 | A1 |
20100160480 | Tomko et al. | Jun 2010 | A1 |
20100160496 | Son | Jun 2010 | A1 |
20100160551 | Marlow et al. | Jun 2010 | A1 |
20100179277 | Soddemann et al. | Jul 2010 | A1 |
20100197863 | Bouquet et al. | Aug 2010 | A1 |
20100210784 | Schmitt et al. | Aug 2010 | A1 |
20100273005 | Kramer et al. | Oct 2010 | A1 |
20100273018 | Scheerder et al. | Oct 2010 | A1 |
20100273924 | Burckhardt | Oct 2010 | A1 |
20100273929 | Kitagawa et al. | Oct 2010 | A1 |
20100280183 | Kou | Nov 2010 | A1 |
20100286299 | Casati et al. | Nov 2010 | A1 |
20100286325 | Balk et al. | Nov 2010 | A1 |
20100297557 | Cameron et al. | Nov 2010 | A1 |
20100323202 | Burckhardt et al. | Dec 2010 | A1 |
20100330376 | Trksak et al. | Dec 2010 | A1 |
20110009515 | Casati | Jan 2011 | A1 |
20110027600 | Hayes | Feb 2011 | A1 |
20110033700 | Caylus | Feb 2011 | A1 |
20110064686 | Zhang et al. | Mar 2011 | A1 |
20110076492 | Fujita et al. | Mar 2011 | A1 |
20110079352 | Shah et al. | Apr 2011 | A1 |
20110104508 | Wang et al. | May 2011 | A1 |
20110118379 | Tighe et al. | May 2011 | A1 |
20110124795 | Van de Zande et al. | May 2011 | A1 |
20110135871 | Yamamoto et al. | Jun 2011 | A1 |
20110136975 | Breiner et al. | Jun 2011 | A1 |
20110144267 | Schuetz et al. | Jun 2011 | A1 |
20110165398 | Shoemake | Jul 2011 | A1 |
20110189253 | Haddock et al. | Aug 2011 | A1 |
20110196084 | Nabuurs et al. | Aug 2011 | A1 |
20110217540 | Sandkuehler et al. | Sep 2011 | A1 |
20110218264 | Casati et al. | Sep 2011 | A1 |
20110236587 | Clark et al. | Sep 2011 | A1 |
20110311631 | Baer et al. | Dec 2011 | A1 |
20120026238 | Ganapathiappan et al. | Feb 2012 | A1 |
20120045485 | Gan et al. | Feb 2012 | A1 |
20120071577 | Pfeffer et al. | Mar 2012 | A1 |
20120077932 | Pfeffer et al. | Mar 2012 | A1 |
20120101181 | Munshi et al. | Apr 2012 | A1 |
20120121903 | Betremieux et al. | May 2012 | A1 |
20120128743 | Hawkett et al. | May 2012 | A1 |
20120140008 | Ganapathiappan et al. | Jun 2012 | A1 |
20120142848 | Bzowej et al. | Jun 2012 | A1 |
20120152459 | Avramidis | Jun 2012 | A1 |
20120156892 | Mevellec et al. | Jun 2012 | A1 |
20120157352 | Musa et al. | Jun 2012 | A1 |
20120165428 | Tilara et al. | Jun 2012 | A1 |
20120168384 | Anzai et al. | Jul 2012 | A1 |
20120172478 | Chang et al. | Jul 2012 | A1 |
20120178884 | Cavallin | Jul 2012 | A1 |
20120225110 | Hashino et al. | Sep 2012 | A1 |
20120237464 | Ahn et al. | Sep 2012 | A1 |
20120245267 | Blanchard et al. | Sep 2012 | A1 |
20120252972 | Balk et al. | Oct 2012 | A1 |
20120288630 | Charkoudian et al. | Nov 2012 | A1 |
20120315265 | Lai et al. | Dec 2012 | A1 |
20130005887 | Lellis et al. | Jan 2013 | A1 |
20130055485 | Zanetta et al. | Mar 2013 | A1 |
20130059119 | Campeau et al. | Mar 2013 | A1 |
20130065976 | Morita et al. | Mar 2013 | A1 |
20130072405 | Favero et al. | Mar 2013 | A1 |
20130122299 | Rand et al. | May 2013 | A1 |
20130123436 | Rand et al. | May 2013 | A1 |
20130129996 | Ahn et al. | May 2013 | A1 |
20130138056 | Kawamura et al. | May 2013 | A1 |
20130143039 | Wilbur et al. | Jun 2013 | A1 |
20130143979 | Kamiyama et al. | Jun 2013 | A1 |
20130149487 | Lunsford et al. | Jun 2013 | A1 |
20130156961 | Heulings et al. | Jun 2013 | A1 |
20130172504 | Phelan | Jul 2013 | A1 |
20130178549 | Ahn et al. | Jul 2013 | A1 |
20130178569 | Guy et al. | Jul 2013 | A1 |
20130183520 | Natori | Jul 2013 | A1 |
20130190468 | Meier et al. | Jul 2013 | A1 |
20130203884 | Blomker et al. | Aug 2013 | A1 |
20130208429 | Liu | Aug 2013 | A1 |
20130231438 | Kim et al. | Sep 2013 | A1 |
20130237673 | Saint-Gerard et al. | Sep 2013 | A1 |
20130253107 | Iyer et al. | Sep 2013 | A1 |
20130263995 | Lutz et al. | Oct 2013 | A1 |
20130272943 | Braga | Oct 2013 | A1 |
20130289135 | Tighe et al. | Oct 2013 | A1 |
20170037263 | Iyer | Feb 2017 | A1 |
Number | Date | Country |
---|---|---|
2079926 | May 1993 | CA |
19822790 | Nov 1999 | DE |
9221720 | Dec 1992 | WO |
2007012432 | Feb 2007 | WO |
Entry |
---|
International Search Report of the European International Searching Authority from International Application No. PCT/EP2014/050197, completed Mar. 18, 2014, 4 pages. |
ASTM International, Standard Specification for Liquid Applied Acrylic Coating Used in Roofing, West Conshohocken, PA, pp. 1-3, Jun. 2005. |
Number | Date | Country | |
---|---|---|---|
20150361301 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
61754241 | Jan 2013 | US |